Cash Flow from Investing Activities: The total change in cash resulting from a company's investments.
Profound Medical (PROF) had Cash Flow from Investing Activities of $-0.24M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$5.98M |
|
$-8.17M |
|
$1.99M |
|
$3.99M |
|
$13.35M |
|
$-7.37M |
|
$-0.78M |
|
$-8.15M |
|
$-8.15M |
|
$-8.17M |
|
$-8.17M |
|
$-8.17M |
|
$-8.17M |
|
$-7.37M |
|
$-7.26M |
|
30.23M |
|
30.23M |
|
$-0.27 |
|
$-0.27 |
|
| Balance Sheet Financials | |
$76.09M |
|
$0.70M |
|
$1.39M |
|
$77.47M |
|
$6.08M |
|
$4.50M |
|
$4.97M |
|
$11.04M |
|
$66.43M |
|
$66.30M |
|
$66.43M |
|
36.29M |
|
| Cash Flow Statement Financials | |
$-38.21M |
|
|
Cash Flow from Investing Activities |
$-0.24M |
$41.14M |
|
$54.91M |
|
$59.72M |
|
$4.81M |
|
$5.49M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
12.52 |
|
-- |
|
-- |
|
0.06 |
|
0.07 |
|
66.77% |
|
-123.29% |
|
-123.29% |
|
-- |
|
-136.32% |
|
-136.76% |
|
$-38.38M |
|
-- |
|
-- |
|
-- |
|
0.08 |
|
0.24 |
|
0.83 |
|
108.42 |
|
-12.30% |
|
-12.33% |
|
-10.55% |
|
-11.52% |
|
$1.83 |
|
$-1.27 |
|
$-1.26 |
|